Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 14, 2023
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
[ Mon, Aug 14th 2023
] - WOPRAI
Kristen Kluska Maintained (TSHA) at Buy with Increased Target to $7 on, Aug 14th, 2023
Kristen Kluska of Cantor Fitzgerald, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Increased Target from $2 to $7 on, Aug 14th, 2023.
Kristen has made no other calls on TSHA in the last 4 months.
There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Kristen
- Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $13 on, Thursday, July 6th, 2023
- Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Friday, June 30th, 2023
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $6 on, Thursday, June 29th, 2023
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $2 on, Monday, May 15th, 2023
